Clinicoprognostic and Histopathological Features of Guttate and Plaque Psoriasis Based on PD-1 Expression

por Chang-Jin Jung, Hee-Joo Yang, Seung-Hyun Bang, Woo-Jin Lee, Chong-Hyun Won, Mi-Woo Lee, Youngsup Song, Sung-Eun Chang
Publicado 2021

Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy

por Jing Zhou, Yuexu Jiang, Yue Huang, Qiongling Wang, Jussuf T. Kaifi, Eric T. Kimchi, Chiswili Yves Chabu, Zhenguo Liu, Trupti Joshi, Guangfu Li
Publicado 2022

Immunotherapy of cancer tumors with inhibition of PD-1 membrane protein and its ligands interaction

por A. V. Chetveryakov, V. L. Tsepelev
Publicado 2021

Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas

por Utpal Kumar, Michael Leonard Anthony, Rishabh Sahai, Ankur Mittal, Prashant Durgapal, Sanjeev Kishore
Publicado 2021

Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis

por Yang You, Xi Guo, Rongyuan Zhuang, Chenlu Zhang, Zhiming Wang, Feng Shen, Yan Wang, Wenshuai Liu, Yong Zhang, Weiqi Lu, Yingyong Hou, Jing Wang, Xuan Zhang, Minzhi Lu, Yuhong Zhou
Publicado 2021

Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy

por Selina K. Wong, Caroline A. Nebhan, Douglas B. Johnson
Publicado 2021

Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted Therapies

por Thierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Publicado 2021

A cellular census of human peripheral immune cells identifies novel cell states in lung diseases

por Dongli Song, Furong Yan, Huirong Fu, Liyang Li, Jie Hao, Zhenhua Zhu, Ling Ye, Yong Zhang, Meiling Jin, Lihua Dai, Hao Fang, Zhenju Song, Duojiao Wu, Xiangdong Wang
Publicado 2021

The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer

por Yaping Chen, Xiao Zheng, Changping Wu, Changping Wu
Publicado 2021

Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis

por Yixi Zhang, Bin La, Baosheng Liang, Yangchun Gu
Publicado 2021

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases

por Xin Cai, Huajie Zhan, Yuguang Ye, Jinjin Yang, Minghui Zhang, Jing Li, Yuan Zhuang
Publicado 2021

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives

por Denis I. Yudin, Konstantin K. Laktionov, Liudmila V. Laktionova, Valeriy V. Breder
Publicado 2021

Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma

por Virginia Liberini, Marco Rubatto, Riccardo Mimmo, Roberto Passera, Francesco Ceci, Paolo Fava, Luca Tonella, Giulia Polverari, Adriana Lesca, Marilena Bellò, Vincenzo Arena, Simone Ribero, Pietro Quaglino, Désirée Deandreis
Publicado 2021

Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects

por Xie S, Hou X, Yang W, Shi W, Yang X, Duan S, Mo F, Liu A, Wang W, Lu X
Publicado 2021

Programmed death‐ligand 1 expression in swine chronic infections and enhancement of interleukin‐2 production via programmed death‐1/programmed death‐ligand 1 blockade

por Otgontuya Ganbaatar, Satoru Konnai, Tomohiro Okagawa, Yutaro Nojima, Naoya Maekawa, Yoshiki Ichikawa, Atsushi Kobayashi, Tomoyuki Shibahara, Yojiro Yanagawa, Hidetoshi Higuchi, Yukinari Kato, Yasuhiko Suzuki, Shiro Murata, Kazuhiko Ohashi
Publicado 2021

Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events

por Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu, Xiubao Ren
Publicado 2021

TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients

por Zahra Modabber, Mehdi Shahbazi, Roghayeh Akbari, Mojgan Bagherzadeh, Alireza Firouzjahi, Mousa Mohammadnia‐Afrouzi
Publicado 2021

Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report S...

por Zheng Yan, Jialin Ma, Shuna Yao, Zhihua Yao, Haiying Wang, Junfeng Chu, Shuang Zhao, Yanyan Liu
Publicado 2021

Cell-Extrinsic Priming Increases Permissiveness of CD4+ T Cells to Human Immunodeficiency Virus Infection by Increasing C–C Chemokine Receptor Type 5 Co-receptor Expression and Cel...

por Jesper G. Pedersen, Johanne H. Egedal, Johanne H. Egedal, Thomas A. Packard, Karthiga Thavachelvam, Guorui Xie, Guorui Xie, Renée Marije van der Sluis, Renée Marije van der Sluis, Warner C. Greene, Nadia R. Roan, Nadia R. Roan, Martin R. Jakobsen
Publicado 2021

Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis

por Xiaofei Wang, Guo Liu, Shu Chen, Huaqiang Bi, Feng Xia, Kai Feng, Kuansheng Ma, Bing Ni
Publicado 2021